[{"address1": "21 Ha\u2019arba\u2019a Street", "city": "Tel Aviv", "zip": "6473921", "country": "Israel", "phone": "972 3 541 3131", "fax": "972 3 541 3144", "website": "https://www.redhillbio.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, advanced unresectable cholangiocarcinoma, prostate cancer, and nuclear radiation protection; RHB-107 (upamostat) for treating outpatients infected with SARS-CoV-2 (COVID-19 disease) and advanced unresectable cholangiocarcinoma; RHB-104 for Crohn's disease; RHB-102 (Bekinda) for the treatment of acute gastroenteritis and gastritis, irritable bowel syndrome with diarrhea, and oncology support anti-emetic; and RHB-204 for pulmonary nontuberculous mycobacteria infections caused by mycobacterium avium complex. The company was incorporated in 2009 and is headquartered in Tel Aviv, Israel.", "fullTimeEmployees": 35, "companyOfficers": [{"maxAge": 1, "name": "Mr. Dror  Ben-Asher", "age": 58, "title": "Co-Founder, Chairman & CEO", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 566465, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Razi  Ingber", "age": 40, "title": "Chief Financial Officer", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 349508, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adi  Frish", "age": 54, "title": "Chief Corporate & Business Development Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 322592, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Patricia  Anderson B.Sc. RAC", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.07, "open": 1.93, "dayLow": 1.9, "dayHigh": 2.4898, "regularMarketPreviousClose": 2.07, "regularMarketOpen": 1.93, "regularMarketDayLow": 1.9, "regularMarketDayHigh": 2.4898, "payoutRatio": 0.0, "beta": 4.434, "trailingPE": "Infinity", "forwardPE": 75.333336, "volume": 1310656, "regularMarketVolume": 1310656, "averageVolume": 216945, "averageVolume10days": 799950, "averageDailyVolume10Day": 799950, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 3998211, "fiftyTwoWeekLow": 1.72, "fiftyTwoWeekHigh": 20.275, "priceToSalesTrailing12Months": 0.49710444, "fiftyDayAverage": 3.39308, "twoHundredDayAverage": 7.099555, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 29149353984, "profitMargins": -1.02797, "floatShares": 11029483648, "sharesOutstanding": 1769120, "sharesShort": 29973, "sharesShortPriorMonth": 33975, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0171, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.04828, "shortRatio": 0.26, "impliedSharesOutstanding": 1752010, "bookValue": -3.63, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -8268000, "trailingEps": 0.0, "forwardEps": 0.03, "lastSplitFactor": "1:25", "lastSplitDate": 1724112000, "enterpriseToRevenue": 3624.189, "enterpriseToEbitda": -2397.94, "52WeekChange": -0.7954751, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 2.26, "recommendationKey": "none", "totalCash": 4617000, "totalCashPerShare": 0.0, "ebitda": -12156000, "totalDebt": 356000, "quickRatio": 0.337, "currentRatio": 0.536, "totalRevenue": 8043000, "revenuePerShare": 6.527, "returnOnAssets": -0.37278, "grossProfits": 4851000, "freeCashflow": -536125, "operatingCashflow": -9369000, "revenueGrowth": 3.82, "grossMargins": 0.60313, "ebitdaMargins": -1.51138, "operatingMargins": -0.69567, "financialCurrency": "USD", "symbol": "RDHL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1744934273, "regularMarketTime": 1744920001, "exchange": "NCM", "messageBoardId": "finmb_104926324", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1357569000000, "postMarketChangePercent": -0.442477, "postMarketPrice": 2.25, "postMarketChange": -0.00999999, "regularMarketChange": 0.19000006, "regularMarketDayRange": "1.9 - 2.4898", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 216945, "fiftyTwoWeekLowChange": 0.53999996, "fiftyTwoWeekLowChangePercent": 0.31395346, "fiftyTwoWeekRange": "1.72 - 20.275", "fiftyTwoWeekHighChange": -18.015, "fiftyTwoWeekHighChangePercent": -0.88853264, "fiftyTwoWeekChangePercent": -79.547516, "earningsTimestamp": 1744282805, "earningsTimestampStart": 1744282805, "earningsTimestampEnd": 1744282805, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 0.0, "epsForward": 0.03, "shortName": "Redhill Biopharma Ltd.", "longName": "RedHill Biopharma Ltd.", "fiftyDayAverageChange": -1.13308, "fiftyDayAverageChangePercent": -0.33393848, "twoHundredDayAverageChange": -4.839555, "twoHundredDayAverageChangePercent": -0.6816701, "priceToBook": -0.6225895, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": 9.178747, "regularMarketPrice": 2.26, "marketState": "CLOSED", "displayName": "RedHill Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]